Injured by Trasylol (Aprotinin)?

Trasylol (also called Aprotinin), a drug used to reduce bleeding during heart surgery, can increase the risk of kidney failure, heart attacks, and strokes, according to a recent study.  Some doctors are urging that the drug be abandoned in favor of safer and cheaper alternatives.

The findings were reported on January 26, 2006 in the New England Journal of Medicine.  News reports say that the Food and Drug Administration is examining the data.  The report in the Journal is based on a study of 4,374 patients having bypass surgery in various countries.

The study reportedly showed that Aprotinin patients had twice the rate of kidney failure, and had increases in heart attacks, heart failure, strokes and a type of brain damage called encephalopathy.

If you or a loved one was injured by Aprotinin and you would like to know more about your legal rights, please call our lawyers or e-mail our law firm by submitting a Potential Case Form.